Naproxen/Esomeprazole Abdi (Esomeprazole, Naproxen)

Naproxen and esomeprazole, the active ingredients in Naproxen/Esomeprazole Abdi, are a non‑steroidal anti‑inflammatory drug (NSAID) and a proton pump inhibitor (PPI) presented as an oral tablet for systemic use. They are employed to relieve pain and inflammation while providing gastric protection against NSAID‑related ulceration in adults.

GNH USA supplies Naproxen/Esomeprazole Abdi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring timely delivery and regulatory compliance.

Naproxen/Esomeprazole is indicated for conditions involving pain, inflammation, or acid‑related gastrointestinal disorders.

- Osteoarthritis: reduces joint pain and inflammation while protecting the stomach lining. - Rheumatoid arthritis: alleviates inflammatory joint symptoms and minimizes ulcer risk associated with NSAID therapy. - Gastro‑esophageal reflux disease: decreases gastric acid secretion, relieving heartburn and esophagitis. - Prevention of NSAID‑induced gastric ulcers: provides gastro‑protective effect when NSAIDs are required for pain management.

The combination may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dyspepsia: upset stomach or indigestion. - Nausea: feeling of queasiness. - Abdominal pain: mild to moderate discomfort. - Headache: transient head pain. - Dizziness: light‑headed sensation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Ulcer perforation: hole formation in the stomach or intestine. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Myocardial infarction: rare heart attack risk with prolonged NSAID use. - Severe liver injury: elevated enzymes or hepatic failure.

Before prescribing Naproxen/Esomeprazole, clinicians should consider several precautionary measures to minimize risk.

- Assess cardiovascular risk: evaluate patient history for heart disease before initiating therapy. - Monitor renal function: NSAIDs can impair kidney function, especially in the elderly. - Avoid in active peptic ulcer disease: risk of severe gastrointestinal bleeding. - Use caution with anticoagulants: increased bleeding potential when combined. - Review concomitant medications: check for interactions that may heighten adverse effects. - Store at ambient temperature: keep in original pack, protect from moisture and light.

Naproxen/Esomeprazole may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - SSRIs or SNRIs: heightened risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may increase risk of renal impairment.